Treatment for short bowel syndrome varies by stage and may include intravenous (IV) nutrition, feeding tubes, dietary changes, medications, or surgery.
Patients with short bowel syndrome are the most complex of patients in gastroenterology. Proper management of these patients -- to treat and to avoid disease and therapy-related complications in a ...
Yahoo Finance: Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
USA Today: Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
Short bowel syndrome (SBS) is a rare condition in which the body cannot absorb enough nutrients because part of the small intestine is missing or not working as well as it should be. This can lead to ...
Nasdaq: Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
A generic form of teduglutide, Teduglutide Viatris (Viatris Limited), that cuts parenteral nutrition needs in patients with short-bowel syndrome (SBS) has received a positive opinion from the European ...
MSN: Short bowel syndrome has no drugs: A new compound could cut liver risk